Dr. Lau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
160 E 34th St
8th floor
New York, NY 10016Phone+1 212-731-5662- Is this information wrong?
Education & Training
University of British ColumbiaClass of 2013
Certifications & Licensure
NY State Medical License 2021 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Daratumumab in STK11 Mutated NSCLC Start of enrollment: 2023 Jun 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- To Crush or Not to Crush: Administering Dabrafenib and Trametinib Through a Nasogastric Tube in a Critically Ill Patient With Nonsmall Cell Lung Cancer - A Case Report...Jang, C., Lau, S., Velcheti, V.> ;Clinical Lung Cancer. 2023 Dec 27
- 2 citationsSpotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.Lynnette Fernandez-Cuesta, Alexandra Sexton-Oates, Leyla Bayat, Matthieu Foll, Sally C M Lau, Ticiana Leal> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
- The Value of Comprehensive Molecular Profiling in Early Stage Lung Cancer.Sally C M Lau> ;Journal of Thoracic Oncology. 2023 Apr 1
- Join now to see all
Press Mentions
TKI plus Chemotherapy Prolonged Survival Outcomes in NSCLC with Brain MetastasesFebruary 22nd, 2023
Hospital Affiliations
NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
